MBIO Mustang Bio Inc

Price (delayed)

$0.7019

Market cap

$5.32M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.47

Enterprise value

-$10.94M

?
Relative Growth: Rel. Growth: 10
Relative Strength: Rel. Strength: 8
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 14

Mustang Bio, Inc. ("Mustang") is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare ...

Highlights
MBIO's equity has surged by 138% year-on-year but it is down by 10% since the previous quarter
MBIO's EPS has surged by 98% year-on-year but it is down by 21% since the previous quarter

Key stats

What are the main financial stats of MBIO

MBIO stock price

How has the Mustang Bio stock price performed over time
Intraday
-5.33%
1 week
10.71%
1 month
-6.66%
1 year
-45.59%
YTD
-28.45%
QTD
-3.59%

Financial performance

How have Mustang Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$3.24M
Net income
-$2.72M
Gross margin
N/A
Net margin
N/A
MBIO's net income has surged by 75% year-on-year but it is down by 42% since the previous quarter
MBIO's operating income has soared by 71% YoY but it is down by 33% from the previous quarter

Price vs fundamentals

How does MBIO's price correlate with its fundamentals

Growth

What is Mustang Bio's growth rate over time

Valuation

What is Mustang Bio stock price valuation
P/E
N/A
P/B
0.62
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
MBIO's EPS has surged by 98% year-on-year but it is down by 21% since the previous quarter
MBIO's equity has surged by 138% year-on-year but it is down by 10% since the previous quarter
The P/B is 92% below the 5-year quarterly average of 7.8 and 35% below the last 4 quarters average of 1.0

Efficiency

How efficient is Mustang Bio business performance
MBIO's ROA has soared by 85% YoY but it is down by 39% from the previous quarter
The company's return on equity fell by 19% QoQ

Dividends

What is MBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MBIO.

Financial health

How did Mustang Bio financials performed over time
Mustang Bio's total assets is 108% more than its total liabilities
The quick ratio has soared by 59% YoY but it fell by 5% QoQ
Mustang Bio's current ratio has surged by 58% YoY but it has decreased by 4.5% QoQ
The company's debt is 100% lower than its equity
MBIO's equity has surged by 138% year-on-year but it is down by 10% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.